QA: Korro Bio Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001703647_2023_Korro_Bio_Inc.pdf

Logs

Graph

Absolute values for 0001703647, Korro Bio Inc

  xvar xval
0 AssetsCurrent 87,493,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,739,000
3 remainder_Assets 31,006,000
4 LiabilitiesCurrent 21,026,000
5 LiabilitiesNoncurrent 26,850,000
6 remainder_Liabilities 4,167,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 29,092,418
9 ResearchAndDevelopmentExpense 41,415,868
10 remainder_Expenses 988,075
11 remainder_Revenues -4,930,907
12 remainder_NetIncome 1,704,227
13 remainder_ComprehensiveNetIncome -371,000
  yvar yval
0 Assets 121,238,000
1 Liabilities 52,043,000
2 Expenses 71,496,361
3 Revenues -4,930,907
4 StockholdersEquity 69,195,000
5 NetIncome -74,723,041
6 ComprehensiveNetIncome -74,908,541
7 BaseVar 125,891,748
8 EconomicCapitalRatiobeforeLimitedLiability 0.876
9 EconomicCapitalRatio 2.20

Edgar->Model Mapping

Feature Distribution

Change over Time